
ImmunityBio
ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming.
Market cap
$2.2b
Enterprise value
$2.6b
Share price
$2.33 IBRX
Authorizing premium user...
ImmunityBio pioneers innovative therapies to conquer disease through immune system reprogramming.